send link to app

drawMD Urology


4.8 ( 4688 ratings )
건강 및 피트 니스 의료
개발자: Visible Health, Inc.
비어 있는

Quickly engage with patients in a meaningful way.

drawMD is a fast, free, simple and effective way to communicate with your patients by sketching on relevant medical illustrations.

drawMD Urology content was developed by physicians and clinical practitioners to facilitate discussions of the most common conditions and procedures. The drawMD platform allows you to easily annotate any condition on our pertinent medical illustration or you can easily upload your own images.

drawMD Urology provides:
•Easy-to-use drawing capability that fits easily into any workflow.
•Clinically validated anatomical artwork.
•A library of backgrounds and stamps (overlays) of anatomy, pathologies, and treatments.
•Easy sharing with patients.
•Anatomic image import functionality to library for annotation.

The medical field does not stop advancing and neither do we! drawMD is always interested in developing new-and-improved illustrations. Let us know what images or features we should add!

Some of the conditions, procedures and anatomy you will find in drawMD Urology:
Bladder Cancer, prostate cancer, bph, interstitial cystitis, hematuria, adrenal mass, adrenal tumor, kidney stone, hydronephrosis, testicular cancer, urinary diversion, prostatectomy, infertility, erectile dysfunction, hypospadias, hernia repair, orchiopexy, cystectomy, nephrectomy, ureteroscopy, and many more.

Our Medical Consultants:

drawMD Urology was created by Dr. Alexander Kutikov and Dr. Todd Morgan. Dr. Kutikov is an Associate Professor of Urologic Oncology in the Department of Surgical Oncology at the Fox Chase Cancer Center in Philadelphia. As a urological oncologist, Dr. Kutikov specializes in surgical treatment of tumors of the adrenals, kidneys, ureters, prostate, bladder, and testes. Dr. Todd Morgan is a Urologic Oncologist at the University of Michigan in Ann Arbor, MI specializing in the treatment of genitourinary cancers. His research interests include proteomics-based identification of renal cell carcinoma biomarkers as well as translational approaches to studying disseminated tumor cells and tumor dormancy in prostate cancer.

Our Sponsor:

drawMD Urology is available for free thanks to the generosity of our sponsor, Boston Scientific. Boston Scientific is dedicated to transforming lives through innovative medical solutions that improve the health of patients around the world. The company is headquartered in Massachusetts. For more information, visit www.bostonscientific.com/urology.